Matrix metalloproteinases: Pro- and anti-angiogenic activities

Keyphrases

• Antiangiogenic Activity 100%
• Angiogenic 100%
• Matrix Metalloproteinases 100%
• Pathologic Processes 37%
• Matrix Metalloproteinase Inhibitors 37%
• Tumor Growth 25%
• Biological Function 25%
• Angiogenesis 25%
• Tumor Metastasis 25%
• Matrix Metalloproteinase Activity 25%
• Arthritis 12%
• Cell-to-cell 12%
• Clinical Trials 12%
• Gene Expression 12%
• Cell-matrix Interactions 12%
• Extracellular Matrix 12%
• Growth Factors 12%
• Biologic Processes 12%
• Inhibitory Activity 12%
• Proenzymes 12%
• Therapeutic Agents 12%
• Tumor Angiogenesis 12%
• Therapeutic Efficacy 12%
• Tumor Invasion 12%
• Vasculature 12%
• Wound Healing 12%
• Potential Therapeutics 12%
• Proteinase 12%
• Synthetic Matrix 12%
• Uterine Involution 12%
• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 12%
• Cytokine Activation 12%
• Control Genes 12%
• Wound Healing Process 12%
• New Vessels 12%
• Mammary Gland Involution 12%
• Non-selective Inhibition 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiangiogenic 100%
• Matrix Metalloproteinase 100%
• Physical Disease by Body Function 30%
• Matrix Metalloproteinase Inhibitor 30%
• Tumor Growth 20%
• Cytokine 20%
• Wound Healing 20%
• Combination Therapy 10%
• Clinical Trial 10%
• Tissue Inhibitor of Metalloproteinase 10%
• Growth Factor 10%
• Tumor Invasion 10%
• Arthritis 10%
• Enzyme Precursor 10%